Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Rakicidins compounds in resistance to clinical pathogenic anaerobic bacteria

A technology of compound and anaerobic bacteria, applied in the field of Rakicidins compound, anti-clinical pathogenic anaerobic bacteria, can solve the problem of high recurrence rate

Active Publication Date: 2016-06-29
FUJIAN INST OF MICROBIOLOGY
View PDF2 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Anaerobic Clostridium difficile infection is the primary cause of antibiotic-associated diarrhea in hospitals. Metronidazole, vancomycin, and fetamycin are currently recommended drugs for the treatment of Clostridium difficile infection. High relapse rates after either nidazole or vancomycin treatment, urgent need for new therapeutic agents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Rakicidins compounds in resistance to clinical pathogenic anaerobic bacteria
  • Application of Rakicidins compounds in resistance to clinical pathogenic anaerobic bacteria
  • Application of Rakicidins compounds in resistance to clinical pathogenic anaerobic bacteria

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Preparation of RakicidinB1

[0023] Step 1: The fermentation and culture conditions of Micromonospora strain FIM02-523 refer to the literature (Jiang Hong, Lin Ru, Zheng Wei, etc. The separation, identification and biological biological activity [J]. Chinese Journal of Antibiotics, 2006, 31(5): 267-270).

[0024] Step 2: Centrifuge the FIM02-523 fermentation broth obtained in Step 1 at 4500rpm for 15 minutes to obtain the mycelium residue, soak the obtained mycelium residue with 2 times the volume of anhydrous methanol or ethanol overnight, and sterilize the bacteria containing alcohol The silk residue was centrifuged again at 4500 rpm for 15 minutes, and the supernatants were combined to obtain a fermentation extract.

[0025] Step 3: HP20 macroporous resin adsorption column chromatography (diameter-to-height ratio 1:5-1:10, column volume 1.5-2.5L): use fermentation extract (40-60L) with 50%-55% Alcohol concentration, the flow rate is 40ml / min for upper column adsorp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biological medicine, in particular to an application of Rakicidins compounds in resistance to clinical pathogenic anaerobic bacteria. Pharmacodynamic experiments indicate that the Rakicidins compounds have good resistant effect on the clinical pathogenic anaerobic bacteria and have the resistant effect on vancomycin enterococcus infection diseases. The Rakicidins compounds can be used for treating diarrhea, enteritis, alimentary infection, oral infection or skin acne caused by clostridium difficile as well as diseases such as urinary tract infection, or skin soft-tissue infection and the like.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the use of a class of Rakicidins compounds for resisting clinical pathogenic anaerobic bacteria. Background technique [0002] Rakicidin A and B were originally reported in the United States, because their 15-membered cyclic lipopeptide structure contains a rare octyl 4-amino-2,4-pentadienoate and has anti-tumor cell activity [McBrienKD, BerryRL , Lowe SE et al. Rakicidins, New Cytotoxic Lipopeptides from Micromonosporasp. Fermentation, Isolation and Characterization [J]. JAntibiot, 1995, 48: 1446]. The structural formula is as follows: [0003] [0004] Yamazaki (2007) found that RakicidinA has excellent hypoxic selective anti-tumor cell activity, and the anti-colon cancer HCT-8 cell activity under hypoxic conditions is 17.5 times that under normal oxygen conditions [YamazakiY, KunimotoS, IkedaD. RakicidinA: ahypoxia -selectivecytotoxin[J].BiolPharmBull.2007,30(2):261-5.]. Takeu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/12A61P31/04A61P17/10A61P1/12A61P1/02A61P1/00A61P13/00A61P17/00C12N1/20C12P21/04C12R1/29
CPCA61K38/12C12P21/02C12N1/205C12R2001/29
Inventor 林风江红连云阳江宏磊周剑赵薇陈丽方东升
Owner FUJIAN INST OF MICROBIOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com